Immuneering Corp — Director's Dealing 2025

Jun 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2025-06-20

Reporting Person: Brakewood Harold Eugene (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-20	Class A Common Stock	P	1900	$2.5285	Acquired	5800	Direct